Diadema Partners LP Alx Oncology Holdings Inc Transaction History
Diadema Partners LP
- $233 Billion
- Q4 2024
A detailed history of Diadema Partners LP transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Diadema Partners LP holds 197,680 shares of ALXO stock, worth $221,401. This represents 0.14% of its overall portfolio holdings.
Number of Shares
197,680Holding current value
$221,401% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding ALXO
# of Institutions
96Shares Held
39.5MCall Options Held
213KPut Options Held
44.8K-
Ven Bio Partners LLC San Francisco, CA9.7MShares$10.9 Million13.33% of portfolio
-
Redmile Group, LLC San Francisco, CA3.69MShares$4.13 Million0.48% of portfolio
-
Tang Capital Management LLC San Diego, CA3.3MShares$3.69 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.69MShares$3.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.5MShares$2.8 Million0.0% of portfolio
About ALX ONCOLOGY HOLDINGS INC
- Ticker ALXO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,747,100
- Market Cap $45.6M
- Description
- ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...